Upgrade to SI Premium - Free Trial

Veru, Inc. (VERU)

11.89 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/15/22)

Latest Headlines

Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) October 4, 2022 4:30 PM - Globe NewsWire Veru to Participate in the Cantor Oncology, Hematology & HemeOnc Conference on September 28th, 2022 September 21, 2022 8:30 AM - Globe NewsWire Veru, Inc. (VERU) Confirms FDA has Updated Meeting Date for Advisory Committee Meeting to Review EUA for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS September 19, 2022 12:16 PM - StreetInsider Veru Announces FDA has Updated the Meeting Date for the Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respi September 19, 2022 12:15 PM - Globe NewsWire UPDATE: Veru, Inc. (VERU) Declines 24% After FDA Panel Postponed by a Month September 19, 2022 11:13 AM - StreetInsider Implied Volatility Movement September 14, 2022 4:28 AM - StreetInsider Implied Volatility Movement September 13, 2022 5:06 AM - StreetInsider Implied Volatility Movement September 12, 2022 4:26 AM - StreetInsider Veru, Inc. (VERU) 3 calls to 1 put September 9, 2022 5:31 AM - StreetInsider Implied Volatility Movement September 9, 2022 5:13 AM - StreetInsider Veru, Inc. (VERU) October option IV elevated September 8, 2022 3:44 AM - StreetInsider Implied Volatility Movement September 8, 2022 3:32 AM - StreetInsider Veru, Inc. (VERU) option IV elevated amid wide price movement September 7, 2022 2:12 PM - StreetInsider Veru, Inc. (VERU) Confirms Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS September 7, 2022 1:46 PM - StreetInsider Veru Announces Date for FDA Advisory Committee Meeting to Review Emergency Use Authorization for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome September 7, 2022 1:45 PM - Globe NewsWire Veru, Inc. (VERU) Extends Decline, Down 19% September 7, 2022 11:54 AM - StreetInsider Veru, Inc. (VERU) Climbs 11%, Covid Treatment to Face FDA Panel on Oct. 6 September 7, 2022 9:17 AM - StreetInsider Veru to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12th, 2022 September 6, 2022 8:30 AM - Globe NewsWire Veru, Inc. (VERU) option IV elevated at 272 August 31, 2022 10:25 AM - StreetInsider Outlook for sabizabulin Unchanged - Oppenheimer Defends Veru (VERU) Despite Weakness August 31, 2022 9:15 AM - StreetInsider Veru, Inc. (VERU) puts active as shares sell off 12% August 30, 2022 10:40 AM - StreetInsider Veru, Inc. (VERU) Lower as Results Questioned August 30, 2022 10:39 AM - StreetInsider Veru, Inc. (VERU) Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin in Australia August 22, 2022 8:34 AM - StreetInsider Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration August 22, 2022 8:30 AM - Globe NewsWire Veru Announces Appointment of Jason Davies to Lead EMEA, LATAM and APAC Infectious Disease Franchise for Veru International Focused on Hospitalized COVID-19 Patients August 19, 2022 8:30 AM - Globe NewsWire Form 4 VERU INC. For: Aug 15 Filed by: Eisenberger Mario August 17, 2022 6:02 PM - SEC Filing Veru, Inc. (VERU) Climbs 14% August 16, 2022 10:42 AM - StreetInsider Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 12, 2022 4:30 PM - Globe NewsWire Form S-8 VERU INC. August 11, 2022 4:42 PM - SEC Filing Form 10-Q VERU INC. For: Jun 30 August 11, 2022 3:39 PM - SEC Filing Veru, Inc. (VERU) call put ratio 3.5 calls to 1 put amid wide price movement August 11, 2022 10:50 AM - StreetInsider Veru, Inc. (VERU) Halted on Volatility August 11, 2022 9:39 AM - StreetInsider Pre-Open Movers: Disney Surges After Subscriber Adds Beat, Six Flags Shares Fall August 11, 2022 8:49 AM - StreetInsider Form 8-K VERU INC. For: Aug 11 August 11, 2022 7:01 AM - SEC Filing Veru, Inc. (VERU) Reports Q3, Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories August 11, 2022 6:31 AM - StreetInsider Veru, Inc. (VERU) Misses Q2 EPS by 12c, Misses on Revenue August 11, 2022 6:31 AM - StreetInsider Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories August 11, 2022 6:30 AM - Globe NewsWire Veru, Inc. (VERU) Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients August 9, 2022 8:31 AM - StreetInsider Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conferenc August 9, 2022 8:30 AM - Globe NewsWire Oppenheime on Veru, Inc. (VERU): 'We believe this update will provide comfort' August 3, 2022 2:36 PM - StreetInsider Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th July 28, 2022 8:30 AM - Globe NewsWire Veru (VERU) Announces EMA's Emergency Task Force Has Initiated the Review of Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries July 27, 2022 11:00 AM - StreetInsider European Medicines Agency’s Emergency Task Force Has Initiated the Review of Veru's Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries July 27, 2022 11:00 AM - Globe NewsWire Stocks with Implied Volatility Movement July 27, 2022 4:51 AM - StreetInsider Veru (VERU) Announce UK’s MHRA Supports Expedited Review of MAA for Sabizabulin Treatment in Hospitalized COVID-19 Patients July 25, 2022 7:31 AM - StreetInsider UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients July 25, 2022 7:30 AM - Globe NewsWire Stocks with Implied Volatility Movement July 25, 2022 3:28 AM - StreetInsider White Diamond Research short Veru, Inc. (VERU) July 18, 2022 9:09 AM - StreetInsider Veru, Inc. (VERU) Climbs 6% July 13, 2022 9:36 AM - StreetInsider Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) July 12, 2022 4:30 PM - Globe NewsWire Veru (VERU) is Top Pick, Little Doubt in EUA for sabizabulin - Oppenheimer Bullish on Shares Ahead of FDA Decision July 11, 2022 5:50 AM - StreetInsider Veru, Inc. (VERU) options active amid wide price movement July 8, 2022 11:24 AM - StreetInsider Veru, Inc. (VERU) Mentioned Cautiously at Culper Research July 8, 2022 10:02 AM - StreetInsider Full Article List